Latest Articles

  • Company Logo for NIO

    Can A New Model Y Challenger Get Nio Stock Back On Track?

    Chinese luxury electric vehicle maker Nio (NYSE:NIO) recently unveiled the first vehicle under its lower-priced Onvo brand, taking on Tesla’s Model Y crossover, which is the world’s best-selling EV. The new vehicle will have a starti...


  • Company Logo for NSC

    Which Is A Better Pick – Norfolk Southern Or Snowflake Stock?

    We think Norfolk Southern stock (NYSE: NSC) and Snowflake stock (NYSE: SNOW) will offer similar returns in the next three years. Although these companies are from different sectors, they share similar market capitalizations of $50-55 billion....


  • Company Logo for LOW

    Up 4% This Year, Will Q1 Results Drive Lowe’s Stock Higher?

    Lowe’s (NYSE: LOW), a home-improvement retailer, is scheduled to report its fiscal first-quarter results on Tuesday, May 21. We expect the company’s stock to likely see little to no movement with revenue and earnings matching market e...


  • Company Logo for NDAQ

    Up 7% YTD, What To Expect From NASDAQ Stock?

    NASDAQ stock  (NASDAQ: NDAQ) has gained 7% YTD  as  compared to an 11% rise in the S&P500 index.  Further,  at  its current price of $62 per share, it  is  almost 7% below its fair value of $67 –  Trefis’  estimate for  NASDAQ’s  valuation...


  • Company Logo for DE

    Is Deere Stock Fully Valued At $400?

    Deere   (NYSE: DE) recently reported its Q2 fiscal 2024 results (fiscal ends in October), with revenues and earnings exceeding the street estimates. The company reported equipment revenue of $13.6 billion and earnings of $8.53 per share, compare...


  • Company Logo for NVAX

    Up 3x In A Week Will Novavax Stock Continue To See Higher Levels?

    The stock price of  Novavax (NASDAQ: NVAX), a Covid-19 vaccine developer, trades at $13 per share, about 96% below its peak level of $320 seen in February 2021. NVAX stock was trading at around $51 in early June 2022, just before the Fed started ...


  • Company Logo for MMM

    Will DexCom Offer Better Returns Than 3M Stock?

    Given its better prospects, we believe DexCom stock (NASDAQ: DXCM) is a better pick than 3M stock (NYSE: MMM). Although these companies are from different sectors, we compare them because of their similar market capitalization of around $50-6...


  • Company Logo for BLK

    Trailing S&P500 BY 11% YTD, Where Is BlackRock Headed?

    BlackRock’s stock  (NYSE: BLK) has given negligible returns YTD as compared to the 11% rise in the S&P500 index over the same period. Further, at its current price of $816 per share, the stock is trading 11% below its fair value of $914 – T...


  • Company Logo for F

    Will The EV Slowdown Benefit Ford Stock?

    Ford stock (NYSE:F) has been a weak performer this year, rising by just 1% year-to-date, compared to the broader S&P 500 which has gained close to 11%, amid concerns of a slowing automotive market. However, Ford’s recent performance ha...


  • Company Logo for COP

    What’s Next For ConocoPhillips’ Stock?

    After a 4% increase since the beginning of this year, at the current price of around $121 per share, we believe ConocoPhillips (NYSE: COP), a pure-play oil and natural gas producer, looks fairly priced at this point. In the recent first quarter, ...



  • Company Logo for PG

    Should You Pick Home Depot Stock Over Procter & Gamble?

    We believe that  Home Depot stock (NYSE: HD) is currently a better pick over Procter & Gamble stock   (NYSE: PG), given its better prospects. Although Home Depot is a consumer cyclical and P&G is a consumer defensive company, we compare...


  • Company Logo for CMCSA

    Will Comcast Stock Recover To Pre-Inflation Shock Highs Of $62?

    Comcast stock (NASDAQ: CMCSA), one of the largest cable TV and internet players in the U.S, currently trades at $40 per share, about 36% below the peak of $61.75 seen in September 2022, and appears to have room for gains. Comcast stock has been...


  • Company Logo for LLY

    How Are Eli Lilly’s Profit Margins Trending?

    Eli Lilly (NYSE: LLY) saw its net income decline by $1 billion or 16% y-o-y to $5.2 billion in 2023. This can primarily be attributed to higher acquired in-process research and development expenses (IPR&D). In this note, we discuss Eli Lill...


Next ▶